Ability Pharmaceuticals SL - Company Review
Ability Pharmaceuticals SL - Company ReviewSummary
Ability Pharmaceuticals SL (Ability Pharma), formerly known as AB Therapeutics S.L., is a clinical stage biopharmaceutical company that focuses on drug discovery and development. It develops human therapeutics to treat lung, pancreatic and gynecological cancers. The company’s lead pipeline product candidate includes ABTL0812, a new drug class of small molecules, developed for the treatment of lung and endometrial cancer. Ability Pharma’s pipeline also includes programs for other indications such as hematological cancers. The company works in partnership with academic institutions to carry research and development activities and later out-license new drug candidates to pharmaceutical companies. Ability Pharma is headquartered in Catalonia, Barcelona, Spain.
This comprehensive company report of Ability Pharmaceuticals SL provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.